[Study on expression of apoptosis related genes in non-small cell carcinoma].
Wei Wei, Yin X, Hong Jin
Abstract
Wei Wei, Yin X, Hong Jin
Abstract
OBJECTIVE: To study the relationship between the expression of apoptosis related genes in the tissue of non-small cell lung carcinoma (NSCLC) and clinicopathology in the tumor. METHODS: The expression of bcl-2, bax, Fas and FasL were detected with immunohistochemistry method in 45 cases of NSCLC. RESULTS: 23 (51%) cases of NSCLC were bcl-2 positive, 38 (84%) were bax positive (P < 0.01), and there was no significant correlation between the expression of bcl-2 and bax protein, but a positive relationship was found between the expression of Fas and FasL (P < 0.01). The positive rate of bcl-2 expression decreased in advanced stages of NSCLC(P < 0.05), the bax expression was lower in cases with poor cell differentiation (P < 0.05), and the FasL expression was higher in adenocarcinoma (P < 0.01). The simultaneous expression of bcl-2 and bax protein was closely correlated with TNM stages (P < 0.05), the differences of bcl-2 protein expression alone in NSCLC with cell differentiation were statistically significant (P = 0.033). CONCLUSIONS: Both bcl-2, bax, Fas and FasL may involve in the regulation of apoptosis and may play an important role in the occurrence and progression of NSCLC.
OpenAlex reports 1 citations for this work. Citation counts describe recorded attention and do not establish research quality.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
OBJECTIVE: To study the relationship between the expression of apoptosis related genes in the tissue of non-small cell lung carcinoma (NSCLC) and clinicopathology in the tumor. METHODS: The expression of bcl-2, bax, Fas and FasL were detected with immunohistochemistry method in 45 cases of NSCLC. RESULTS: 23 (51%) cases of NSCLC were bcl-2 positive, 38 (84%) were bax positive (P < 0.01), and there was no significant correlation between the expression of bcl-2 and bax protein, but a positive relationship was found between the expression of Fas and FasL (P < 0.01). The positive rate of bcl-2 expression decreased in advanced stages of NSCLC(P < 0.05), the bax expression was lower in cases with poor cell differentiation (P < 0.05), and the FasL expression was higher in adenocarcinoma (P < 0.01). The simultaneous expression of bcl-2 and bax protein was closely correlated with TNM stages (P < 0.05), the differences of bcl-2 protein expression alone in NSCLC with cell differentiation were statistically significant (P = 0.033). CONCLUSIONS: Both bcl-2, bax, Fas and FasL may involve in the regulation of apoptosis and may play an important role in the occurrence and progression of NSCLC.
Key concepts: Fas ligand, Apoptosis, Immunohistochemistry, BAX Protein, Cancer research, Cell, Carcinoma, Gene